A lack of AMPK in adipocytes exacerbated the detrimental effects of an HFD, including NAFLD and insulin resistance, due to reductions in the metabolic activity of BAT19. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.